Table 1 Patient characteristics (n = 179)
From: Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma
Parameter | Value |
|---|---|
Age at surgery, years, median (IQR) | 75 (66–79) |
Sex, no. (%): | |
Male | 132 (73.7) |
Female | 47 (26.3) |
Surgical technique, no. (%): | |
Open | 16 (8.9) |
Laparoscopic | 163 (91.1) |
Tumor location, no. (%): | |
Renal pelvis | 96 (53.6) |
Ureter | 81 (45.3) |
Both | 2 (1.1) |
Tumor grade, no. (%): | |
G1 | 10 (5.6) |
G2 | 94 (52.5) |
G3 | 75 (41.9) |
Pathological T stage, no. (%): | |
Ta/1/is | 91 (50.8) |
T2 | 13 (7.3) |
T3 | 70 (39.1) |
T4 | 5 (2.8) |
Pathological N stage, no. (%): | |
N0/x | 157 (87.7) |
N1 | 16 (8.9) |
N2 | 6 (3.4) |
N3 | 0 (0) |
Adjuvant chemotherapy, no. (%): | |
Yes | 39 (21.8) |
No | 140 (78.2) |
Bladder cancer status, no. (%): | |
No | 145 (81.0) |
Previous | 19 (10.6) |
Synchronous | 15 (8.4) |
AGR, median (IQR) | 1.41 (1.18–1.63) |
Follow-up duration, months, median (IQR) | 35 (17–63) |